CVFG LLC’s Indivior Pharmaceuticals INDV Stock Holding History

CVFG LLC’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	44,709 -330	-0.7%	-$12K	0.19%	106
2026 Q1	$1.37M	Buy	+45,039	New	+$1.49M	0.17%	119

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CVFG LLC's INDV Position: Q2 2026 in Review

CVFG LLC reduced its Indivior Pharmaceuticals (INDV) stake by 0.73% in Q2 2026, selling an estimated $12K and leaving 44,709 shares worth $1.83M. The position accounts for 0.19% of the portfolio, ranked #106.

CVFG LLC first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

CVFG LLC held 44,709 shares of Indivior Pharmaceuticals worth $1.83M as of Q2 2026.
CVFG LLC sold 330 Indivior Pharmaceuticals shares in Q2 2026, an estimated $12K.
Indivior Pharmaceuticals made up 0.19% of CVFG LLC's portfolio in Q2 2026, its #106 holding.
CVFG LLC first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on CVFG LLC's 13F filing for Q2 2026, filed 11 Aug 2026.